期刊文献+

血清曲霉IgG型抗体检测对器官移植术后肺曲霉感染的诊断 被引量:1

The signifcance of serum anti-aspergillus IgG antibody test in the diagnosis of invasive pulmonary aspergillosis after transplantation
下载PDF
导出
摘要 目的:探讨血清曲霉IgG型抗体检测在器官移植术后肺曲霉感染中的诊断价值。方法:酶免分析法检测肺曲霉感染高危患者血清中曲霉特异性IgG抗体。结果:血清曲霉IgG抗体检查的灵敏度和特异度分别为50%和100%。移植后1个月内血清曲霉IgG抗体检测的灵敏度为40%,而1个月后其灵敏度为80%。结论:特异性曲霉IgG抗体测定不能作为器官移植后肺曲霉病的早期诊断标准,但对感染后期的回顾性诊断和随访有一定意义。 Objective To explore the significance of the serum anti-aspergillus IgG antibody test in the diagnosis of pulmonary aspergillosis after transplantation. Methods The serum specific anti-aspergillus antibody was detected with enzyme immunoassay (EIA) in 60 patients at risk of invasive pulmonary aspergillosis. Results The sensitivity and the specificity of the serum anti-aspergillus IgG antibody test by EIA were 50% and 100% respectively. The sensitivity declined to 40% within first month of the post-transplantative, but elevated to 80% later. Conclusions The specific antiaspergillus IgG antibody test by EIA is less useful in the early diagnosis of invasive pulmonary asper gillosis after transplantation, but may be a useful marker for the retrospective diagnosis and the follow-up.
出处 《诊断学理论与实践》 2006年第2期113-115,共3页 Journal of Diagnostics Concepts & Practice
关键词 侵袭性肺曲霉感染 移植 抗体 酶联免疫分析 Invasive pulmonary aspergillosis Transplantation Antibody Enzyme immunoassay
  • 相关文献

参考文献11

  • 1[1]Singh N,Paterson DL.Aspergillus infections in transplant recipients[J].Clin Microbiol Rev,2005,18(1),44-69.
  • 2[2]Pinel C,Fricker-Hidalgo H,Lebeau B,et al.Detection of circulating Aspergillus fumigatus galactomannan:value and limits of the Platelia test for diagnosing invasive aspergillosis[j].J Clin Microbiol,2003,41(5):2184-2186.
  • 3[3]Pickering JW,Sant HW,Bowles CA,et al.Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections[J].J Clin Microbiol,2005,43(12):5957-5962.
  • 4朱小敏,周新,蔡逸婷,韩伟.血清半乳甘露聚糖检测对器官移植术后侵袭性肺曲霉病的诊断价值[J].中国抗感染化疗杂志,2005,5(4):215-217. 被引量:36
  • 5[5]Ascioglu S,Rex JH,de Pauw B,et al.Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants:an international consensus[J].Clin Infect Dis,2002,34(1):7-14.
  • 6[6]Donnelly JP.Infection in the neutropenic and haematopoietic stem cell transplant recipient[J].Curr Opin Infect Dis,2000,13(4):337-342.
  • 7[7]Cornet M,Fleury L,Maslo C,et al.Epidemiology of invasive aspergillosis in France:a six-year multicentric survey in the Greater Paris area[J].J Hosp Infect,2002,51(4):288-296.
  • 8[8]Kappe R,Schulze-Berge A,Sonntag HG.Evaluation of eight antibody tests and one antigen test for the diagnosis of invasive aspergillosis[J].Mycoses,1996,39(1-2):13-23.
  • 9[9]Chan CM,Woo PC,Leung AS,et al.Detection of antibodies specific to an antigenic cell wall galactomannoprotein for serodiagnosis of Aspergillus fumigatus aspergillosis[J].J Clin Microbiol,2002,40(6):2041-2045.
  • 10[10]Soubani AO,Chandrasekar PH.The clinical spectrum of pulmonary aspergillosis[J].Chest,2002,121(6):1988-1999.

二级参考文献8

  • 1Kotloff RM, Ahya VN, Crawford SW. Pulmonary complications of solid organ and hematopoietic stem cell transplantation[J]. Am J Respir Crit Care Med,2004,170: 22-48.
  • 2Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis[J]. N Engl J Med,2002,347: 408-415.
  • 3Denning DW. Therapeutic outcome in invasive aspergillosis[J].Clin Infect Dis, 1996,23 : 608-615.
  • 4Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus[J]. Clin Infect Dis,2002,34: 7-14.
  • 5Bretagne S, Marmorat-Khuong A, M Kuentz, et al. Serum Aspergillus galactomannan antigen testing by sandwich ELISA: practical use in neutropenic patients[J]. J Infect, 1997,35: 7-15.
  • 6Walsh TJ, Shoham S, Petraitiene R, et al. Detection of galactomannan antigenemia in patients receiving piperacillintazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction[J]. J Clin Microbiol,2004,42 : 4744-4748.
  • 7Gangneux JP, Lavarde D, Bretagne S, et al. Transient Aspergillus antigenemia: think of milk[J]. Lancet, 2002,359 : 1251.
  • 8Maertens J, Verhaegen J, Lagrou K, et al. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation[J].Blood,2001,97: 1604-1610.

共引文献35

同被引文献15

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部